Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Amarin
Company Monitoring Page for Amarin
latest headlines for company on cafepharma
No News Equals Bad News for Amarin Investors
Motley Fool
Sat, 11/17/12 - 02:05 pm
Tags:
Amarin
Amarin Pushed Closer to Solo Vascepa Launch By Another NCE Delay
The Street
Sat, 11/17/12 - 02:01 pm
Tags:
Amarin
,
Vascepa
,
fish oil
3 Potential Partners for Amarin
Motley Fool
Thu, 11/15/12 - 10:43 am
Tags:
M&A
,
Amarin
,
AstraZeneca
,
Merck
,
Eli Lilly
Amarin's Dilemma: Sell Vascepa Or Sell Itself?
Seeking Alpha
Tue, 11/13/12 - 11:16 am
Tags:
Amarin
,
Vascepa
Amarin Releases Q3 Results: What You Need To Know
Seeking Alpha
Mon, 11/12/12 - 11:27 am
Tags:
earnings
,
Amarin
Biotech Weekend Recap: Important Developments And Big Releases
Seeking Alpha
Sun, 11/11/12 - 09:49 am
Tags:
Amarin
,
Vivus
,
Dendreon
,
Arena Pharmaceuticals
,
Pharmacyclics
,
Biomarin
Amarin Still Playing the Dating Game
Motley Fool
Sun, 11/11/12 - 09:31 am
Tags:
Amarin
,
Vascepa
Amarin Still Playing the Dating Game
Motley Fool
Fri, 11/9/12 - 09:50 am
Tags:
Amarin
,
M&A
,
AstraZeneca
Does Amarin Need the FDA to Play NCE?
Motley Fool
Fri, 11/9/12 - 08:53 am
Tags:
Amarin
,
Vascepa
,
FDA
,
NCE
Amarin Stagnates On Frustrating M&A Speculation And (More) Waiting
Seeking Alpha
Wed, 11/7/12 - 11:22 am
Tags:
M&A
,
Amarin
,
GSK
Buyout Buzz: The most frequently cited takeover targets in biotech
Fierce Biotech
Tue, 11/6/12 - 04:32 pm
Tags:
biotech
,
M&A
,
Amarin
,
Achillion
,
ONYX Pharmaceuticals
,
Actelion
,
Elan
,
Forest Labs
,
Medivation
,
Biomarin
,
Indenix
How Do You Solve a Problem Like Vascepa?
Motley Fool
Mon, 11/5/12 - 11:01 am
Tags:
Vascepa
,
Amarin
How Does The Patent Exclusivity Factor Affect The 3 Top Dividend-Paying Healthcare Companies?
Seeking Alpha
Fri, 11/2/12 - 10:26 am
Tags:
patents
,
Amarin
,
AstraZeneca
,
Bristol-Myers Squibb
,
GSK
3 Biotechs Investors Should Be Scared Of
Motley Fool
Wed, 10/31/12 - 11:40 am
Tags:
Amarin
,
Alexion
,
Spectrum Pharmaceuticals
Why These 3 Biotech Stocks Are Winning
Motley Fool
Sat, 10/27/12 - 11:32 am
Tags:
Cyclacel
,
Gilead Sciences
,
Amarin
AstraZeneca may launch cash bid for Amarin, Daily Mail reports
Yahoo/Fly on the Wall
Wed, 10/24/12 - 10:59 am
Tags:
AstraZeneca
,
M&A
,
Amarin
Wall Street Loves Amarin. Should You?
Motley Fool
Mon, 10/22/12 - 10:31 am
Tags:
Amarin
,
Vascepa
Amarin strength attributed to pervious comments in peer review journal
Yahoo/Fly on the Wall
Thu, 10/18/12 - 12:48 pm
Tags:
Amarin
3 Biotechs With Good FDA News
Motley Fool
Wed, 10/17/12 - 11:49 am
Tags:
FDA
,
Arqule
,
Threshold Pharmaceuticals
,
Amarin
Biotech Weekend Recap: Clinical Trials, Company Files
Seeking Alpha
Sun, 10/14/12 - 11:04 am
Tags:
Eli Lilly
,
Valeant Pharmaceuticals
,
Lexicon Pharmaceuticals
,
Sarepta Therapeutics
,
Amarin
,
NPS Pharmaceuticals
,
Aeterna Zentaris
Pages
« first
‹ previous
…
11
12
13
14
15
16
17
18
19
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.